Instil Bio, Inc.
NASDAQ:TIL
Overview | Financials
Company Name | Instil Bio, Inc. |
Symbol | TIL |
Currency | USD |
Price | 22.57 |
Market Cap | 147,289,337 |
Dividend Yield | 0% |
52-week-range | 9.62 - 92 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Bronson Crouch |
Website | https://instilbio.com |
An error occurred while fetching data.
About Instil Bio, Inc.
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD